HEADER VIRAL PROTEIN 01-OCT-19 6UIS TITLE HIV-1 M184V REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DCTP COMPND MOL_ID: 1; COMPND 2 MOLECULE: P66 REVERSE TRANSCRIPTASE/RNASEH; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXORIBONUCLEASE H, P66 RT; COMPND 5 EC: 2.7.7.49,2.7.7.7,3.1.26.13; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: P51 REVERSE TRANSCRIPTASE/RNASEH; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: EXORIBONUCLEASE H, P51 RT; COMPND 12 EC: 2.7.7.49,2.7.7.7,3.1.26.13; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PRIMER DNA; COMPND 17 CHAIN: P; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: TEMPLATE DNA; COMPND 21 CHAIN: T; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 3 SUBTYPE B (ISOLATE HXB2); SOURCE 4 ORGANISM_COMMON: HIV-1; SOURCE 5 ORGANISM_TAXID: 11706; SOURCE 6 STRAIN: ISOLATE HXB2; SOURCE 7 GENE: GAG-POL; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 12 SUBTYPE B (ISOLATE HXB2); SOURCE 13 ORGANISM_COMMON: HIV-1; SOURCE 14 ORGANISM_TAXID: 11706; SOURCE 15 STRAIN: ISOLATE HXB2; SOURCE 16 GENE: GAG-POL; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 22 ORGANISM_TAXID: 11676; SOURCE 23 MOL_ID: 4; SOURCE 24 SYNTHETIC: YES; SOURCE 25 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 26 ORGANISM_TAXID: 11676 KEYWDS HIV-1 REVERSE TRANSCRIPTASE NRTI POLYMERASE DNA COMPLEX, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.B.LANSDON REVDAT 3 11-OCT-23 6UIS 1 REMARK REVDAT 2 08-JAN-20 6UIS 1 JRNL REVDAT 1 25-DEC-19 6UIS 0 JRNL AUTH M.HUNG,E.J.TOKARSKY,L.LAGPACAN,L.ZHANG,Z.SUO,E.B.LANSDON JRNL TITL ELUCIDATING MOLECULAR INTERACTIONS OFL-NUCLEOTIDES WITH JRNL TITL 2 HIV-1 REVERSE TRANSCRIPTASE AND MECHANISM OF M184V-CAUSED JRNL TITL 3 DRUG RESISTANCE. JRNL REF COMMUN BIOL V. 2 469 2019 JRNL REFN ESSN 2399-3642 JRNL PMID 31872074 JRNL DOI 10.1038/S42003-019-0706-X REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.335 REMARK 3 COMPLETENESS FOR RANGE (%) : 50.4 REMARK 3 NUMBER OF REFLECTIONS : 37225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.378 REMARK 3 FREE R VALUE TEST SET COUNT : 2002 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.4500 - 6.6183 0.54 2693 154 0.1721 0.2533 REMARK 3 2 6.6183 - 5.2553 0.53 2640 150 0.1868 0.2340 REMARK 3 3 5.2553 - 4.5917 0.52 2594 146 0.1565 0.2157 REMARK 3 4 4.5917 - 4.1721 0.52 2604 145 0.1526 0.2031 REMARK 3 5 4.1721 - 3.8732 0.52 2593 148 0.1630 0.2254 REMARK 3 6 3.8732 - 3.6449 0.52 2579 149 0.1851 0.2619 REMARK 3 7 3.6449 - 3.4625 0.52 2589 144 0.1955 0.2661 REMARK 3 8 3.4625 - 3.3118 0.52 2576 145 0.1975 0.2711 REMARK 3 9 3.3118 - 3.1843 0.52 2587 147 0.2061 0.2616 REMARK 3 10 3.1843 - 3.0745 0.52 2581 148 0.2196 0.2983 REMARK 3 11 3.0745 - 2.9783 0.51 2535 143 0.2324 0.3401 REMARK 3 12 2.9783 - 2.8932 0.50 2476 142 0.2379 0.3287 REMARK 3 13 2.8932 - 2.8171 0.46 2305 129 0.2328 0.3444 REMARK 3 14 2.8171 - 2.7500 0.37 1871 112 0.2360 0.3387 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.351 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.149 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 8886 REMARK 3 ANGLE : 1.162 12238 REMARK 3 CHIRALITY : 0.048 1338 REMARK 3 PLANARITY : 0.006 1394 REMARK 3 DIHEDRAL : 19.001 3410 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6UIS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1000244691. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37257 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.748 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3KK1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2% PEG 4000, 100MM MES PH 6.0, 10MM REMARK 280 MAGNESIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.65000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.65000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 83.77700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 84.55450 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 83.77700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 84.55450 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 51.65000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 83.77700 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 84.55450 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 51.65000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 83.77700 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 84.55450 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -89.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 786 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 SER A -1 REMARK 465 SER A 0 REMARK 465 ILE A 135 REMARK 465 ASN A 136 REMARK 465 ASN A 137 REMARK 465 GLU A 138 REMARK 465 THR A 139 REMARK 465 PRO A 140 REMARK 465 GLY A 141 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 LEU A 560 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 PHE B 87 REMARK 465 TRP B 88 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 93 REMARK 465 ILE B 94 REMARK 465 PRO B 95 REMARK 465 LEU B 214 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 TYR B 232 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 GLU B 430 REMARK 465 LYS B 431 REMARK 465 GLU B 432 REMARK 465 PRO B 433 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 465 DA P 802 REMARK 465 DC P 803 REMARK 465 DA P 804 REMARK 465 DA T 701 REMARK 465 DT T 702 REMARK 465 DG T 725 REMARK 465 DT T 726 REMARK 465 DG T 727 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 DG P 805 P OP1 OP2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 354 NH1 ARG B 356 2.16 REMARK 500 N2 DG P 817 O HOH P 901 2.18 REMARK 500 O ASN A 54 NH2 ARG A 143 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 DC T 709 O3' DC T 709 C3' -0.050 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DOC P 822 O3' - P - OP2 ANGL. DEV. = 14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 113 56.39 36.18 REMARK 500 VAL A 184 -118.47 55.54 REMARK 500 PRO A 243 131.20 -39.65 REMARK 500 PRO A 247 173.84 -56.09 REMARK 500 GLU A 248 20.85 -146.05 REMARK 500 VAL A 276 18.91 -148.10 REMARK 500 LYS A 347 77.49 -115.81 REMARK 500 ALA A 355 2.89 -151.42 REMARK 500 PRO A 420 170.99 -59.20 REMARK 500 LYS B 20 48.07 -142.47 REMARK 500 PHE B 61 -153.20 -149.87 REMARK 500 LYS B 66 -127.81 52.76 REMARK 500 PRO B 97 94.73 -63.69 REMARK 500 VAL B 184 -122.71 52.54 REMARK 500 PHE B 346 -1.46 70.45 REMARK 500 LYS B 347 69.81 -103.52 REMARK 500 PRO B 421 7.60 -65.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 604 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 110 OD2 REMARK 620 2 VAL A 111 O 92.9 REMARK 620 3 ASP A 185 OD2 95.5 88.1 REMARK 620 4 DCP A 601 O1A 86.8 173.6 85.6 REMARK 620 5 DCP A 601 O1B 169.6 97.1 88.0 83.6 REMARK 620 6 DCP A 601 O3G 85.5 104.2 167.7 82.2 89.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 605 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD1 REMARK 620 2 ASP A 549 OD1 90.7 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DCP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 605 DBREF 6UIS A 1 560 UNP P04585 POL_HV1H2 588 1147 DBREF 6UIS B 1 440 UNP P04585 POL_HV1H2 588 1027 DBREF 6UIS P 802 822 PDB 6UIS 6UIS 802 822 DBREF 6UIS T 701 727 PDB 6UIS 6UIS 701 727 SEQADV 6UIS MET A -11 UNP P04585 INITIATING METHIONINE SEQADV 6UIS GLY A -10 UNP P04585 EXPRESSION TAG SEQADV 6UIS SER A -9 UNP P04585 EXPRESSION TAG SEQADV 6UIS SER A -8 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -7 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -6 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -5 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -4 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -3 UNP P04585 EXPRESSION TAG SEQADV 6UIS HIS A -2 UNP P04585 EXPRESSION TAG SEQADV 6UIS SER A -1 UNP P04585 EXPRESSION TAG SEQADV 6UIS SER A 0 UNP P04585 EXPRESSION TAG SEQADV 6UIS VAL A 184 UNP P04585 MET 771 ENGINEERED MUTATION SEQADV 6UIS CYS A 258 UNP P04585 GLN 845 ENGINEERED MUTATION SEQADV 6UIS SER A 280 UNP P04585 CYS 867 ENGINEERED MUTATION SEQADV 6UIS VAL B 184 UNP P04585 MET 771 ENGINEERED MUTATION SEQADV 6UIS SER B 280 UNP P04585 CYS 867 ENGINEERED MUTATION SEQRES 1 A 572 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER PRO SEQRES 2 A 572 ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS PRO SEQRES 3 A 572 GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU THR SEQRES 4 A 572 GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR GLU SEQRES 5 A 572 MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO GLU SEQRES 6 A 572 ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS LYS SEQRES 7 A 572 ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG GLU SEQRES 8 A 572 LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN LEU SEQRES 9 A 572 GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SER SEQRES 10 A 572 VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER VAL SEQRES 11 A 572 PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE THR SEQRES 12 A 572 ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG TYR SEQRES 13 A 572 GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER PRO SEQRES 14 A 572 ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU PRO SEQRES 15 A 572 PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN TYR SEQRES 16 A 572 VAL ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE GLY SEQRES 17 A 572 GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS LEU SEQRES 18 A 572 LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS GLN SEQRES 19 A 572 LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU HIS SEQRES 20 A 572 PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO GLU SEQRES 21 A 572 LYS ASP SER TRP THR VAL ASN ASP ILE CYS LYS LEU VAL SEQRES 22 A 572 GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY ILE SEQRES 23 A 572 LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR LYS SEQRES 24 A 572 ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA GLU SEQRES 25 A 572 LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU PRO SEQRES 26 A 572 VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU ILE SEQRES 27 A 572 ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR TYR SEQRES 28 A 572 GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR GLY SEQRES 29 A 572 LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP VAL SEQRES 30 A 572 LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR GLU SEQRES 31 A 572 SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS LEU SEQRES 32 A 572 PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR GLU SEQRES 33 A 572 TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE VAL SEQRES 34 A 572 ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU GLU SEQRES 35 A 572 LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL ASP SEQRES 36 A 572 GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA GLY SEQRES 37 A 572 TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR LEU SEQRES 38 A 572 THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA ILE SEQRES 39 A 572 TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN ILE SEQRES 40 A 572 VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN ALA SEQRES 41 A 572 GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN ILE SEQRES 42 A 572 ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU ALA SEQRES 43 A 572 TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU GLN SEQRES 44 A 572 VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS VAL LEU SEQRES 1 B 440 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 440 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 440 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 440 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 440 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 440 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 440 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 440 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 440 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 440 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 440 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 440 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 440 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 440 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 440 TYR VAL ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 440 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 440 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 440 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 440 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 440 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 440 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 440 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 440 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 440 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 440 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 440 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 440 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 440 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 440 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 440 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 440 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 440 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 440 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 440 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE SEQRES 1 P 21 DA DC DA DG DT DC DC DC DT DG DT DT DC SEQRES 2 P 21 DG DG DG DC DG DC DC DOC SEQRES 1 T 27 DA DT DG DG DG DG DG DG DC DG DC DC DC SEQRES 2 T 27 DG DA DA DC DA DG DG DG DA DC DT DG DT SEQRES 3 T 27 DG HET DOC P 822 18 HET DCP A 601 28 HET SO4 A 602 5 HET SO4 A 603 5 HET MG A 604 1 HET MG A 605 1 HETNAM DOC 2',3'-DIDEOXYCYTIDINE-5'-MONOPHOSPHATE HETNAM DCP 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE HETNAM SO4 SULFATE ION HETNAM MG MAGNESIUM ION FORMUL 3 DOC C9 H14 N3 O6 P FORMUL 5 DCP C9 H16 N3 O13 P3 FORMUL 6 SO4 2(O4 S 2-) FORMUL 8 MG 2(MG 2+) FORMUL 10 HOH *145(H2 O) HELIX 1 AA1 THR A 27 GLU A 44 1 18 HELIX 2 AA2 PHE A 77 THR A 84 1 8 HELIX 3 AA3 HIS A 96 LEU A 100 5 5 HELIX 4 AA4 ALA A 114 VAL A 118 5 5 HELIX 5 AA5 PHE A 124 ALA A 129 5 6 HELIX 6 AA6 GLY A 155 ASN A 175 1 21 HELIX 7 AA7 GLU A 194 TRP A 212 1 19 HELIX 8 AA8 PRO A 217 HIS A 221 5 5 HELIX 9 AA9 VAL A 254 SER A 268 1 15 HELIX 10 AB1 VAL A 276 LEU A 283 1 8 HELIX 11 AB2 THR A 296 GLU A 312 1 17 HELIX 12 AB3 ASN A 363 TRP A 383 1 21 HELIX 13 AB4 GLN A 394 TYR A 405 1 12 HELIX 14 AB5 THR A 473 ASP A 488 1 16 HELIX 15 AB6 SER A 499 ALA A 508 1 10 HELIX 16 AB7 SER A 515 LYS A 528 1 14 HELIX 17 AB8 GLY A 544 SER A 553 1 10 HELIX 18 AB9 THR B 27 GLU B 44 1 18 HELIX 19 AC1 PHE B 77 THR B 84 1 8 HELIX 20 AC2 PRO B 97 LYS B 103 5 7 HELIX 21 AC3 GLY B 112 VAL B 118 5 7 HELIX 22 AC4 PHE B 124 ALA B 129 5 6 HELIX 23 AC5 SER B 134 GLU B 138 5 5 HELIX 24 AC6 LYS B 154 ASN B 175 1 22 HELIX 25 AC7 GLY B 196 ARG B 211 1 16 HELIX 26 AC8 VAL B 254 SER B 268 1 15 HELIX 27 AC9 VAL B 276 LEU B 282 1 7 HELIX 28 AD1 THR B 296 GLU B 312 1 17 HELIX 29 AD2 ASN B 363 GLY B 384 1 22 HELIX 30 AD3 GLN B 394 TRP B 402 1 9 HELIX 31 AD4 THR B 403 TYR B 405 5 3 HELIX 32 AD5 PRO B 420 GLN B 428 1 9 SHEET 1 AA1 3 ILE A 47 LYS A 49 0 SHEET 2 AA1 3 ARG A 143 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 AA1 3 PHE A 130 THR A 131 -1 N PHE A 130 O TYR A 144 SHEET 1 AA2 2 VAL A 60 LYS A 64 0 SHEET 2 AA2 2 TRP A 71 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 AA3 3 SER A 105 LEU A 109 0 SHEET 2 AA3 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AA3 3 VAL A 179 TYR A 183 -1 N TYR A 183 O ASP A 186 SHEET 1 AA4 3 PHE A 227 TRP A 229 0 SHEET 2 AA4 3 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 AA4 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AA5 2 TRP A 252 THR A 253 0 SHEET 2 AA5 2 VAL A 292 ILE A 293 -1 O ILE A 293 N TRP A 252 SHEET 1 AA6 5 LYS A 347 TYR A 354 0 SHEET 2 AA6 5 TRP A 337 GLU A 344 -1 N ILE A 341 O LEU A 349 SHEET 3 AA6 5 ILE A 326 LYS A 331 -1 N ILE A 326 O TYR A 342 SHEET 4 AA6 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AA6 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AA7 2 HIS A 361 THR A 362 0 SHEET 2 AA7 2 GLN A 512 SER A 513 -1 O GLN A 512 N THR A 362 SHEET 1 AA8 5 GLN A 464 THR A 470 0 SHEET 2 AA8 5 LEU A 452 THR A 459 -1 N ALA A 455 O VAL A 467 SHEET 3 AA8 5 GLU A 438 ALA A 446 -1 N TYR A 441 O VAL A 458 SHEET 4 AA8 5 GLU A 492 THR A 497 1 O VAL A 496 N PHE A 440 SHEET 5 AA8 5 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 AA9 3 ILE B 47 LYS B 49 0 SHEET 2 AA9 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 AA9 3 PHE B 130 ILE B 132 -1 N PHE B 130 O TYR B 144 SHEET 1 AB1 2 VAL B 60 LYS B 64 0 SHEET 2 AB1 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 AB2 3 SER B 105 ASP B 110 0 SHEET 2 AB2 3 ASP B 186 SER B 191 -1 O LEU B 187 N LEU B 109 SHEET 3 AB2 3 VAL B 179 TYR B 183 -1 N TYR B 181 O TYR B 188 SHEET 1 AB3 2 TRP B 252 THR B 253 0 SHEET 2 AB3 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 AB4 5 LYS B 347 TYR B 354 0 SHEET 2 AB4 5 GLN B 336 GLU B 344 -1 N TYR B 339 O GLY B 352 SHEET 3 AB4 5 LEU B 325 GLY B 333 -1 N ILE B 326 O TYR B 342 SHEET 4 AB4 5 PRO B 387 LEU B 391 1 O LYS B 388 N LEU B 325 SHEET 5 AB4 5 TRP B 414 PHE B 416 1 O GLU B 415 N PHE B 389 LINK O3' DC P 821 P DOC P 822 1555 1555 1.58 LINK OD2 ASP A 110 MG MG A 604 1555 1555 1.72 LINK O VAL A 111 MG MG A 604 1555 1555 1.91 LINK OD2 ASP A 185 MG MG A 604 1555 1555 2.24 LINK OD1 ASP A 443 MG MG A 605 1555 1555 2.95 LINK OD1 ASP A 549 MG MG A 605 1555 1555 2.87 LINK O1A DCP A 601 MG MG A 604 1555 1555 2.15 LINK O1B DCP A 601 MG MG A 604 1555 1555 2.20 LINK O3G DCP A 601 MG MG A 604 1555 1555 2.20 CISPEP 1 PRO A 225 PRO A 226 0 3.46 CISPEP 2 PRO A 420 PRO A 421 0 -0.81 CISPEP 3 GLY A 543 GLY A 544 0 3.61 SITE 1 AC1 19 LYS A 65 ARG A 72 ASP A 110 VAL A 111 SITE 2 AC1 19 GLY A 112 ASP A 113 ALA A 114 TYR A 115 SITE 3 AC1 19 GLN A 151 VAL A 184 ASP A 185 LYS A 220 SITE 4 AC1 19 MG A 604 HOH A 718 HOH A 751 DOC P 822 SITE 5 AC1 19 DG T 705 DG T 706 HOH T 802 SITE 1 AC2 8 ARG A 206 GLY A 436 ALA A 437 ASN A 460 SITE 2 AC2 8 ARG A 461 HOH A 709 HOH A 722 ALA B 288 SITE 1 AC3 1 GLN A 340 SITE 1 AC4 4 ASP A 110 VAL A 111 ASP A 185 DCP A 601 SITE 1 AC5 3 ASP A 443 ASP A 498 ASP A 549 CRYST1 167.554 169.109 103.300 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005968 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005913 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009681 0.00000